EDIT: Editas Medicine Inc. Stocks News on July 26, 2024

EDIT

MT Newswires

17 days ago

RBC Cuts Price Target on Editas Medicine to $8 From $11, Keeps Sector Perform, Speculative Risk

EDIT

Simply Wall St.

22 days ago

Editas Medicine (NASDAQ:EDIT) investors are sitting on a loss of 90% if they invested three years ago

EDIT

Insider Monkey

a month ago

Is Editas Medicine, Inc. (EDIT) One of the Best Biotech Penny Stocks to Buy Now?

EDIT

Insider Monkey

a month ago

What Makes Editas Medicine, Inc. (EDIT) One of the Best Small-Cap Stocks with Highest Upside Potential?

EDIT

Zacks

a month ago

Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies

EDIT

MT Newswires

a month ago

Editas Medicine Says Its Gene Editing Potential Treatment for Sickle-Cell Disease Found Well-Tolerated in Phase 1/2 Trial

EDIT

GlobeNewswire

a month ago

Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress

EDIT

GlobeNewswire

a month ago

Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual Congress

Lotto 6/49 - $64 million up for grabs in the next draw!

EDIT

CNW Group

2 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

EDIT

Simply Wall St.

2 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

EDIT

AFP

2 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

EDIT

Simply Wall St.

2 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

EDIT

Simply Wall St.

2 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

EDIT

Barrons.com

2 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

EDIT

Simply Wall St.

2 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

EDIT

Simply Wall St.

2 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

EDIT

Investor's Business Daily

2 months ago

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

EDIT

Business Wire

2 months ago

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

EDIT

Investor's Business Daily

2 months ago

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

EnviroGold Global Closes First Tranche of Private Placement

EDIT

GlobeNewswire

2 months ago

EnviroGold Global Closes First Tranche of Private Placement

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

EDIT

GuruFocus.com

2 months ago

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

How markets digested hot jobs print: Top takeaways

EDIT

Yahoo Finance Video

2 months ago

How markets digested hot jobs print: Top takeaways

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

EDIT

PR Newswire

2 months ago

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

EDIT

GlobeNewswire

2 months ago

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

EDIT

Zacks

2 months ago

Editas (EDIT) Down 2.3% Since Last Earnings Report: Can It Rebound?

EDIT

MT Newswires

2 months ago

Evercore ISI Cuts Price Target on Editas Medicine to $7 From $15, Maintains In Line Rating

EDIT

GuruFocus.com

2 months ago

EVP, Chief Financial Officer Erick Lucera Sells 22,337 Shares of Editas Medicine Inc (EDIT)

EDIT

GuruFocus.com

2 months ago

Director Jessica Hopfield Acquires 45,000 Shares of Editas Medicine Inc (EDIT)

EDIT

MT Newswires

2 months ago

Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing

EDIT

GlobeNewswire

2 months ago

Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June

EDIT

Simply Wall St.

2 months ago

Editas Medicine, Inc. (NASDAQ:EDIT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

EDIT

GlobeNewswire

3 months ago

Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting

EDIT

Insider Monkey

3 months ago

Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript

EDIT

Motley Fool

3 months ago

1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?

EDIT

Zacks

3 months ago

Editas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down

EDIT

MT Newswires

3 months ago

Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating

EDIT

MT Newswires

3 months ago

Morgan Stanley Upgrades Editas Medicine to Equal-Weight From Underweight

EDIT

Simply Wall St.

3 months ago

Editas Medicine First Quarter 2024 Earnings: Misses Expectations

EDIT

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Editas Medicine Inc Earnings Call

EDIT

Zacks

3 months ago

Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates

EDIT

Associated Press Finance

3 months ago

Editas: Q1 Earnings Snapshot

EDIT

GlobeNewswire

3 months ago

Editas Medicine Announces First Quarter 2024 Results and Business Updates

EDIT

Simply Wall St.

3 months ago

Editas Medicine, Inc. (NASDAQ:EDIT) is a favorite amongst institutional investors who own 71%

EDIT

GlobeNewswire

3 months ago

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

EDIT

MT Newswires

3 months ago

Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration

EDIT

GlobeNewswire

3 months ago

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

12 Under-the-Radar Stocks With Massive Upside for 2024

EDIT

Insider Monkey

3 months ago

12 Under-the-Radar Stocks With Massive Upside for 2024

EDIT

Zacks

3 months ago

Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know

EDIT

GlobeNewswire

3 months ago

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

EDIT

Zacks

4 months ago

Why Is Editas (EDIT) Down 26.2% Since Last Earnings Report?

EDIT

Motley Fool

5 months ago

1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.

EDIT

GuruFocus.com

5 months ago

Insider Sells Shares of Editas Medicine Inc (EDIT)

1 Beaten-Down Stock With 55% Upside, According to Wall Street

EDIT

Motley Fool

5 months ago

1 Beaten-Down Stock With 55% Upside, According to Wall Street

EDIT

Motley Fool

5 months ago

Why Editas Medicine Stock Soared as Much as 42% Higher This Week

EDIT

Simply Wall St.

5 months ago

Editas Medicine, Inc. (NASDAQ:EDIT) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

EDIT

Insider Monkey

5 months ago

Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript

EDIT

Zacks

5 months ago

Editas (EDIT) Q4 Earnings & Revenues Top Estimates, Stock Up

EDIT

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Editas Medicine Inc Earnings Call

EDIT

Zacks

5 months ago

Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates

EDIT

GuruFocus.com

5 months ago

Editas Medicine Inc (EDIT) Reports Improved Financials and Advances in Gene Editing Trials

EDIT

Associated Press Finance

5 months ago

Editas: Q4 Earnings Snapshot

EDIT

GlobeNewswire

5 months ago

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates

EDIT

GlobeNewswire

5 months ago

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events

EDIT

Zacks

5 months ago

Wall Street Analysts Believe Editas (EDIT) Could Rally 80%: Here's is How to Trade

EDIT

Zacks

5 months ago

Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology

5 Biotech Stocks to Consider for Your Portfolio in 2024

EDIT

Zacks

5 months ago

5 Biotech Stocks to Consider for Your Portfolio in 2024

EDIT

Insider Monkey

6 months ago

Top 11 CRISPR Stocks To Invest In

EDIT

Zacks

6 months ago

What Makes Editas (EDIT) a New Buy Stock

EDIT

GlobeNewswire

6 months ago

Editas Medicine to Participate in Upcoming Investor Conferences

EDIT

PR Newswire

6 months ago

Allegiant Reports December 2023 Traffic

What To Expect From Skyworks Solutions’s (SWKS) Q1 Earnings

EDIT

StockStory

6 months ago

What To Expect From Skyworks Solutions’s (SWKS) Q1 Earnings

2 Under-the-Radar Stocks With Incredible Upside Potential

EDIT

Motley Fool

6 months ago

2 Under-the-Radar Stocks With Incredible Upside Potential

EDIT

Simply Wall St.

6 months ago

Editas Medicine (NASDAQ:EDIT) shareholders have endured a 87% loss from investing in the stock three years ago

EDIT

Associated Press Finance

6 months ago

Brookline: Q4 Earnings Snapshot

SAPIENS TO ANNOUNCE FOURTH QUARTER and YEAR-END 2023 FINANCIAL RESULTS ON FEBRUARY 20, 2024

EDIT

PR Newswire

6 months ago

SAPIENS TO ANNOUNCE FOURTH QUARTER and YEAR-END 2023 FINANCIAL RESULTS ON FEBRUARY 20, 2024

EDIT

Motley Fool

6 months ago

Could Editas Medicine Become the Next CRISPR Therapeutics?

Bears are Losing Control Over Centerra Gold Inc. (CGAU), Here's Why It's a 'Buy' Now

EDIT

Zacks

6 months ago

Bears are Losing Control Over Centerra Gold Inc. (CGAU), Here's Why It's a 'Buy' Now

Wall Street Analysts Predict a 26.85% Upside in Accolade (ACCD): Here's What You Should Know

EDIT

Zacks

6 months ago

Wall Street Analysts Predict a 26.85% Upside in Accolade (ACCD): Here's What You Should Know

How ACM Research (ACMR) Stock Stands Out in a Strong Industry

EDIT

Zacks

6 months ago

How ACM Research (ACMR) Stock Stands Out in a Strong Industry

Sensata Paves the Way for Sustainable Water Use with New Smart Pressure Sensor for In-Meter Monitoring

EDIT

Business Wire

6 months ago

Sensata Paves the Way for Sustainable Water Use with New Smart Pressure Sensor for In-Meter Monitoring

AI Ascending: 3 Under-the-Radar Tech Stocks Poised for Explosive Growth

EDIT

InvestorPlace

6 months ago

AI Ascending: 3 Under-the-Radar Tech Stocks Poised for Explosive Growth

Immatics Announces Pricing of $175 Million Public Offering

EDIT

GlobeNewswire

6 months ago

Immatics Announces Pricing of $175 Million Public Offering

7 Mighty Healthcare Stocks Changing the Game of Medicine

EDIT

InvestorPlace

6 months ago

7 Mighty Healthcare Stocks Changing the Game of Medicine

Nicolet Bankshares Inc Reports Mixed Annual Results and Strong Q4 Growth

EDIT

GuruFocus.com

6 months ago

Nicolet Bankshares Inc Reports Mixed Annual Results and Strong Q4 Growth

EDIT

Reuters

6 months ago

REFILE-UPDATE 4-Talos Energy to acquire QuarterNorth Energy for $1.29 bln

EDIT

Motley Fool

6 months ago

Down 88%, Could Editas Medicine Be a Good Investment Now?

EDIT

InvestorPlace

6 months ago

3 Stocks to Buy in the Booming Field of Gene Editing

EDIT

Zacks

6 months ago

Zacks.com featured highlights include GigaCloud Technology, SkyWest, Ramaco Resources, Eastman Chemical and Catalyst Pharmaceuticals

Does 89BIO (ETNB) Have the Potential to Rally 168.77% as Wall Street Analysts Expect?

EDIT

Zacks

7 months ago

Does 89BIO (ETNB) Have the Potential to Rally 168.77% as Wall Street Analysts Expect?

Armour Residential REIT (ARR) Increases Despite Market Slip: Here's What You Need to Know

EDIT

Zacks

7 months ago

Armour Residential REIT (ARR) Increases Despite Market Slip: Here's What You Need to Know

SourceMark Medical Announces Expanded Partnership with Gentherm Medical

EDIT

PR Newswire

7 months ago

SourceMark Medical Announces Expanded Partnership with Gentherm Medical

EDIT

GlobeNewswire

7 months ago

Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference

Returns On Capital At HealthStream (NASDAQ:HSTM) Have Hit The Brakes

EDIT

Simply Wall St.

7 months ago

Returns On Capital At HealthStream (NASDAQ:HSTM) Have Hit The Brakes

German American Bank named a Best Bank 2024 by Newsweek

EDIT

GlobeNewswire

7 months ago

German American Bank named a Best Bank 2024 by Newsweek

EDIT

Business Wire

7 months ago

NextDecade Announces $50 Million Senior Secured Revolving Credit Facility and $12.5 Million Interest Term Loan

EDIT

GlobeNewswire

7 months ago

Americold Announces Leadership Updates

Napco (NSSC) Upgraded to Strong Buy: Here's Why

EDIT

Zacks

7 months ago

Napco (NSSC) Upgraded to Strong Buy: Here's Why

EDIT

Zacks Small Cap Research

7 months ago

MDXG: Axiofill Update & Series B Conversion

Seabridge Gold Board Announces Senior Management Changes

EDIT

Newsfile

7 months ago

Seabridge Gold Board Announces Senior Management Changes

Owning 29% shares,institutional owners seem interested in Paysafe Limited (NYSE:PSFE),

EDIT

Simply Wall St.

7 months ago

Latest Editas Medicine Inc. (EDIT) News on July 26, 2024

Share on Social Networks: